Candel Therapeutics (CADL)

• Market cap: $270M
• 1 day: -3.91%
• 5 days: -4.66%
• 1 month: -17.06%
• 3 months: -2.19%
• 6 months: -3.91%
• Year to date: -9.74%
• 1 year: -37.93%
• 5 years: -29.86%
• 10 years: -29.86%
• Sector: Healthcare
• Industry: Biotechnology

About: Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Employees: 38